Dataset
Hydroxyzine; LC-ESI-Q; MS; POS; 60 V
Chemical Information
| InChI | InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2 |
|---|---|
| SMILES | OCCOCCN(C3)CCN(C3)C(c(c2)cccc2)c(c1)ccc(Cl)c1 |
| InChI Key | ZQDWXGKKHFNSQK-UHFFFAOYSA-N |
| Molecular Formula | C21H27ClN2O2 |
| Exact Mass | 374.176 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA002930 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 3658 | PubChem |
| PD009966 | ProbesDrugs |
| hydroxyzine | Atlas |
| 14853297 | PubChem: Thomson Pharma |
| 68-88-2 | ACToR |
| PA449943 | PharmGKB |
| LSM-5103 | LINCS |
| 1987151 | eMolecules |
| 145968 | Brenda |
| HMDB0014697 | Human Metabolome Database |
| 146702 | Brenda |
| CB2547530 | ChemicalBook |
| 145054 | Brenda |
| hydroxyzine | DailyMed |
| SCHEMBL4491 | SureChEMBL |
| HYDROXYZINE | DailyMed |
| 22875 | BindingDB |
| HYDROXYZINE HYDROCHLORIDE | rxnorm |
| VISTARIL | rxnorm |
| HYDROXYZINE PAMOATE | rxnorm |
| VISTARIL | clinicaltrials |
| ATARAX | clinicaltrials |
| ORGATRAX | clinicaltrials |
| HYDROXYZINE | clinicaltrials |
| HYDROXYZINE DIHYDROCHLORIDE | clinicaltrials |
| HYDROXYZINE HYDROCHLORIDE | clinicaltrials |
| HYDROXYZINE PAMOATE | clinicaltrials |
| HY-B0548 | MedChemExpress |
| 30S50YM8OG | FDA SRS |
| MCULE-6995009916 | Mcule |
| 1400 | DrugCentral |
| 7199 | Guide to Pharmacology |
| J4.860G | Nikkaji |
| HYDROXYZINE | rxnorm |
| DTXSID8023137 | EPA CompTox Dashboard |
| CHEMBL896 | ChEMBL |
| 5818 | ChEBI |
| DB00557 | DrugBank |
| C07045 | KEGG Ligand |
| The data in this table is sourced from UniChem at EBI. | |